Keywords: ASPA, aspartoacylase; BBB, blood–brain barrier; CD, Canavan disease; CNS, central nervous system; ERT, enzyme replacement therapy; GFAP, glial fibrillary acidic protein; IBA, ionized calcium binding adaptor protein-1; NAA, N-acetyl-l-aspartate; NECA, 1-(6